Michael Bloomberg Proclaims “OneMedForum Days” in New York City
The OneMedForum was recognized by Michael R. Bloomberg, Mayor of New York City, as an important event supporting innovation in the healthcare and life science industries.
Featured Articles
NeuroPace Files with FDA for Epilepsy Device
NeuroPace, a company focused on implantable devices for the treatment of brain disorders, announced Thursday that it has filed for Pre-Market Approval with the U.S. Food and Drug Administration for its investigational device for epilepsy patients.
OneMedForum New York 2010: Key Days for Innovation in Healthcare
Though selected in order to give a platform to lesser recognized businesses, the companies presenting demonstrated the vast diversity of the healthcare and life science spaces.
FDA Approves Implantable Telescope for the Eye
The U.S. Food and Drug Administration has approved the first implantable eye telescope to improve vision in patients with end-stage age-related macular degeneration.
OneMedForum New York 2010 Successfully Brings Together Innovators and Investors
The mid-year conference’s goal was to bring together a promising group of 75 private and microcap companies in 25 different healthcare sectors with a prominent group of European and U.S. institutional investor groups.
Clinical Trial of GeoVax’s AIDS Vaccine Moves Forward
As President Obama prepares to release his U.S. AIDS strategy, at least one pharmaceutical company is readying a crucial clinical trial of its vaccine against HIV/AIDS.
Celgene Acquires Abraxis In $2.9 Billion Deal
Celgene has acquired Abraxis BioScience in a cash-and-stock deal valued at $2.9 billion, reports FierceBiotech.
OneMedForum to Highlight the Newest, Most Promising Med Tech Innovations
OneMedPlace announced that it will showcase to investors and entrepreneurs the newest and most promising new medical technologies in the region.
Special Session On Health Savings Accounts at OneMedForum New York 2010
Health Savings Accounts have been a central part of healthcare reform plans under both the Bush and Obama administrations, touted as a way for consumers to save on medical costs. But how will they be affected by the healthcare reform bill passed in March?
Making Reimbursement Work In a Post-Healthcare Reform World
The passage of healthcare reform in March brought a wave of reimbursement-related headaches to the life science industry.